The role of natural killer cells in autoimmune blistering diseases

References

• Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, Senman B, Szczepanik M, Telenti A, Askenase PW, Compans RW, von Andrian UH. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol. 2010; 11 12: 1127–1135.
   PubMed Web of Science ®Google Scholar
• Stern JN, Keskin DB, Barteneva N, Zuniga J, Yunis EJ, Ahmed AR. Possible role of natural killer cells in pemphigus vulgaris—preliminary observations. Clin Exp Immunol. 2008; 152 3: 472–481.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Takeuchi K, Ohshima K. Extranodal NK/T-cell lymphoma: Diagnosis and treatment cues. Hematol Oncol. 2008; 26 2: 66–72.
   PubMed Web of Science ®Google Scholar
• Shibuya A, Nagayoshi K, Nakamura K, Nakauchi H. Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 1995; 85 12: 3538–3546.
   PubMed Web of Science ®Google Scholar
• Greer JP, Mosse CA. Natural killer-cell neoplasms. Curr Hematol Malig Rep. 2009; 4 4: 245–252.
   PubMedGoogle Scholar
• Perricone R, Perricone C, De Carolis C, Shoenfeld Y. NK cells in autoimmunity: A two-edg'd weapon of the immune system. Autoimmun Rev. 2008; 7 5: 384–390.
   PubMed Web of Science ®Google Scholar
• Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science. 2011; 331 6013: 44–49.
   PubMed Web of Science ®Google Scholar
• Caligiuri MA. Human natural killer cells. Blood. 2008; 112 3: 461–469.
   PubMed Web of Science ®Google Scholar
• Blum KS, Pabst R. Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs?. Immunol Lett. 2007; 108 1: 45–51.
   PubMed Web of Science ®Google Scholar
• Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol. 2004; 5 10: 996–1002.
   PubMed Web of Science ®Google Scholar
• Shi FD, Ljunggren HG, Sarvetnick N. Innate immunity and autoimmunity: From self-protection to self-destruction. Trends Immunol. 2001; 22 2: 97–101.
   PubMed Web of Science ®Google Scholar
• Lunemann A, Lunemann JD, Munz C. Regulatory NK-cell functions in inflammation and autoimmunity. Mol Med. 2009; 15 9–10: 352–358.
   PubMed Web of Science ®Google Scholar
• von Bubnoff D, Andrès E, Hentges F, Bieber T, Michel T, Zimmer J. Natural killer cells in atopic and autoimmune diseases of the skin. J Allergy Clin Immunol. 2010; 125 1: 60–68.
   PubMed Web of Science ®Google Scholar
• Grando SA, Glukhenky BT, Drannik GN, Kostromin AP, Romanenko AB. The effect of experimental haemocarbofiltration upon activity of mononuclear cells from normal and autoimmune patients. Immunology. 1989; 66 1: 138–142.
   PubMed Web of Science ®Google Scholar
• Oswald E, Fisch P, Jakob T, Bruckner-Tuderman L, Martin SF, Rensing-Ehl A. Reduced numbers of circulating gammadelta T cells in patients with bullous pemphigoid. Exp Dermatol. 2009; 18 11: 991–993.
   PubMed Web of Science ®Google Scholar
• Carayannopoulos LN, Yokoyama WM. Recognition of infected cells by natural killer cells. Curr Opin Immunol. 2004; 16 1: 26–33.
   PubMed Web of Science ®Google Scholar
• Cooper MA, Colonna M, Yokoyama WM. Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep. 2009; 10 10: 1103–1110.
   PubMed Web of Science ®Google Scholar
• Poli A, Michel T, Thérésine M, Andrès E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: An important NK cell subset. Immunology. 2009; 126 4: 458–465.
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer. 2002; 2 11: 850–861.
   PubMed Web of Science ®Google Scholar
• Vivier E, Tomasello E, Baratin M, Walzer T. Ugolini S Functions of natural killer cells. Nat Immunol. 2008; 9 5: 503–510.
   PubMed Web of Science ®Google Scholar
• Berke G. The CTL's kiss of death. Cell. 1995; 81 1: 9–12.
   PubMed Web of Science ®Google Scholar
• Mocikat R, Braumuller H, Gumy A, Egeter O, Ziegler H, Reusch U, Bubeck A, Louis J, Mailhammer R, Riethmüller G, Koszinowski U, Röcken M. Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity. 2003; 19 4: 561–569.
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y. Activation of NK cell cytotoxicity. Mol Immunol. 2005; 42 4: 501–510.
   PubMed Web of Science ®Google Scholar
• Wallach D, Fellous M, Revel M. Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature. 1982; 299 5886: 833–836.
   PubMed Web of Science ®Google Scholar
• Maher SG, Romero-Weaver AL, Scarzello AJ, Gamero AM. Interferon: Cellular executioner or white knight?. Curr Med Chem. 2007; 14 12: 1279–1289.
   PubMed Web of Science ®Google Scholar
• Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, Jouanguy E, Boisson-Dupuis S, Fieschi C, Picard C, Casanova JL. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: Molecular, cellular, and clinical features. Semin Immunol. 2006; 18 6: 347–361.
   PubMed Web of Science ®Google Scholar
• Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003; 3 10: 781–790.
   PubMed Web of Science ®Google Scholar
• Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001; 19:197–223.
   PubMed Web of Science ®Google Scholar
• Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002; 195 3: 343–351.
   PubMed Web of Science ®Google Scholar
• Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, Haldeman B, Ostrander CD, Kaifu T, Chabannon C, Moretta A, West R, Xu W, Vivier E, Levin SD. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med. 2009; 206 7: 1495–1503.
   PubMed Web of Science ®Google Scholar
• Lanier LL. NK cell recognition. Annu Rev Immunol. 2005; 23:225–274.
   PubMed Web of Science ®Google Scholar
• O'Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology. 2006; 117 1: 1–10.
   PubMed Web of Science ®Google Scholar
• Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagné F, Ugolini S, Vivier E. Human NK cell education by inhibitory receptors for MHC class I. Immunity. 2006; 25 2: 331–342.
   PubMed Web of Science ®Google Scholar
• Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood. 2005; 105 11: 4416–4423.
   PubMed Web of Science ®Google Scholar
• Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005; 436 7051: 709–713.
   PubMed Web of Science ®Google Scholar
• Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol. 2006; 6 7: 520–531.
   PubMed Web of Science ®Google Scholar
• Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol. 1998; 161 11: 5821–5824.
   PubMed Web of Science ®Google Scholar
• Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response. J Immunol. 1999; 162 8: 4511–4520.
   PubMed Web of Science ®Google Scholar
• Zhou R, Wei H, Tian Z. NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice. J Immunol. 2007; 178 4: 2141–2147.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang J, Tian Z. The regulatory effect of natural killer cells: Do “NK-reg cells” exist?. Cell Mol Immunol. 2006; 3 4: 241–254.
   PubMed Web of Science ®Google Scholar
• Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25 − T lymphocytes. Exp Hematol. 2007; 35 3: 416–425.
   PubMed Web of Science ®Google Scholar
• Maroof A, Beattie L, Zubairi S, Svensson M, Stager S, Kaye PM. Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity. 2008; 29 2: 295–305.
   PubMed Web of Science ®Google Scholar
• Deniz G, Erten G, Kucuksezer UC, Kocacik D, Karagiannidis C, Aktas E, Akdis CA, Akdis M. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol. 2008; 180 2: 850–857.
   PubMed Web of Science ®Google Scholar
• Kheradmand T, Trivedi PP, Wolf NA, Roberts PC, Swanborg RH. Characterization of a subset of bone marrow-derived natural killer cells that regulates T cell activation in rats. J Leukoc Biol. 2008; 83 5: 1128–1135.
   PubMed Web of Science ®Google Scholar
• Lo CK, Lam QL, Sun L, Wang S, Ko KH, Xu H, Wu CY, Zheng BJ, Lu L. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum. 2008; 58 9: 2700–2711.
   PubMed Web of Science ®Google Scholar
• Giuliani M, Giron-Michel J, Negrini S, Vacca P, Durali D, Caignard A, Le Bousse-Kerdiles C, Chouaib S, Devocelle A, Bahri R, Durrbach A, Taoufik Y, Ferrini S, Croce M, Mingari MC, Moretta L, Azzarone B. Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. PLoS One. 2008; 3 5: e2241.
   PubMed Web of Science ®Google Scholar
• Roy S, Barnes PF, Garg A, Wu S, Cosman D, Vankayalapati R. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol. 2008; 180 3: 1729–1736.
   PubMed Web of Science ®Google Scholar
• O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol. 2006; 7 5: 507–516.
   PubMed Web of Science ®Google Scholar
• Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009; 457 7229: 557–561.
   PubMed Web of Science ®Google Scholar
• Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci USA. 2009; 106 6: 1915–1919.
   PubMed Web of Science ®Google Scholar
• Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, Arnon TI, Gazit R, Joseph A, Schjetne KW, Steinle A, Porgador A, Mevorach D, Goldman-Wohl D, Yagel S, LaBarre MJ, Buckner JH, Mandelboim O. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest. 2004; 114 11: 1612–1623.
   PubMed Web of Science ®Google Scholar
• Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity. 2009; 31 1: 15–23.
   PubMed Web of Science ®Google Scholar
• Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL. Gammadelta T cells: An important source of IL-17. Curr Opin Immunol. 2008; 20 3: 353–357.
   PubMed Web of Science ®Google Scholar
• Benghiat FS, Charbonnier LM, Vokaer B, De Wilde V, Le Moine A. Interleukin 17-producing T helper cells in alloimmunity. Transplant Rev (Orlando). 2009; 23 1: 11–18.
   PubMedGoogle Scholar
• Zenewicz LA, Flavell RA. IL-22 and inflammation: Leukin' through a glass onion. Eur J Immunol. 2008; 38 12: 3265–3268.
   PubMed Web of Science ®Google Scholar
• Wu L, Van Kaer L. Natural killer T cells and autoimmune disease. Curr Mol Med. 2009; 9 1: 4–14.
   PubMed Web of Science ®Google Scholar
• Johansson S, Berg L, Hall H, Höglund P. NK cells: Elusive players in autoimmunity. Trends Immunol. 2005; 26 11: 613–618.
   PubMed Web of Science ®Google Scholar
• Colucci F, Di Santo JP, Leibson PJ. Natural killer cell activation in mice and men: Different triggers for similar weapons?. Nat Immunol. 2002; 3 9: 807–813.
   PubMed Web of Science ®Google Scholar
• Ly D, Mi QS, Hussain S, Delovitch TL. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. J Immunol. 2006; 177 6: 3695–3704.
   PubMed Web of Science ®Google Scholar
• Liu R, La Cava A, Bai XF, Jee Y, Price M, Campagnolo DI, Christadoss P, Vollmer TL, Van Kaer L, Shi FD. Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. J Immunol. 2005; 175 12: 7898–7904.
   PubMed Web of Science ®Google Scholar
• Kojo S, Adachi Y, Keino H, Taniguchi M, Sumida T. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 2001; 44 5: 1127–1138.
   PubMed Web of Science ®Google Scholar
• van der Vliet HJ, von Blomberg BM, Nishi N, Reijm M, Voskuyl AE, van Bodegraven AA, Polman CH, Rustemeyer T, Lips P, van den Eertwegh AJ, Giaccone G, Scheper RJ, Pinedo HM. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol. 2001; 100 2: 144–148.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Nakamura Y, Matsuzuka F, Takamura Y, Miyauchi A, Iwatani Y. Decrease of intrathyroidal CD161+Valpha24+Vbeta11+ NKT cells in Graves' disease. Endocr J. 2008; 55 1: 199–203.
   PubMed Web of Science ®Google Scholar
• Ahmed AR, Graham J, Jordon RE, Provost TT. Pemphigus: Current concepts. Ann Intern Med. 1980; 92 3: 396–405.
   PubMed Web of Science ®Google Scholar
• Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet. 1999; 354 9179: 667–672.
   PubMed Web of Science ®Google Scholar
• Lever WF. Pemphigus and pemphigoid. A review of the advances made since 1964. J Am Acad Dermatol. 1979; 1 1: 2–31.
   PubMed Web of Science ®Google Scholar
• Sami N, Bhol KC, Beutner EH, Plunkett RW, Leiferman KM, Foster CS, Ahmed AR. Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: Molecular characterization of both autoantibodies. Clin Immunol. 2001; 100 2: 219–227.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Amagai M, Tanikawa A, Suzuki S, Ikeda Y, Nishikawa T, Kawakami Y, Kuwana M. T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. J Invest Dermatol. 2007; 127 2: 324–330.
   PubMed Web of Science ®Google Scholar
• Sami N, Ahmed AR. Dual diagnosis of pemphigus and pemphigoid. Retrospective review of thirty cases in the literature. Dermatology. 2001; 202 4: 293–301.
   PubMed Web of Science ®Google Scholar
• Keskin DB, Stern JN, Fridkis-Hareli M, Razzaque Ahmed A. Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy. Cytokine. 2008; 41 3: 315–321.
   PubMed Web of Science ®Google Scholar
• Ugolini S, Vivier E. Immunology: Natural killer cells remember. Nature. 2009; 457 7229: 544–545.
   PubMed Web of Science ®Google Scholar
• Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009; 361 5: 496–509.
   PubMed Web of Science ®Google Scholar
• McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006; 3 8: e297.
   PubMed Web of Science ®Google Scholar
• Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, Gonzalez J, Krueger JG, Lowes MA. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol. 2009; 129 1: 79–88.
   PubMed Web of Science ®Google Scholar
• Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006; 203 10: 2271–2279.
   PubMed Web of Science ®Google Scholar
• Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol. 2008; 128 5: 1207–1211.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007; 445 7128: 648–651.
   PubMed Web of Science ®Google Scholar
• Boniface K, Blom B, Liu YJ, de Waal Malefyt R. From interleukin-23 to T-helper 17 cells: Human T-helper cell differentiation revisited. Immunol Rev. 2008; 226:132–146.
   PubMed Web of Science ®Google Scholar
• Nickoloff BJ. The cytokine network in psoriasis. Arch Dermatol. 1991; 127 6: 871–884.
   PubMedGoogle Scholar
• Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial. Lancet. 2005; 366 9494: 1367–1374.
   PubMed Web of Science ®Google Scholar
• Bos JD, de Rie MA, Teunissen MB, Piskin G. Psoriasis: Dysregulation of innate immunity. Br J Dermatol. 2005; 152 6: 1098–1107.
   PubMed Web of Science ®Google Scholar
• de Cid R, Riveira-Munoz E, Zeeuwen PL, Robarge J, Liao W, Dannhauser EN, Giardina E, Stuart PE, Nair R, Helms C, Escaramís G, Ballana E, Martín-Ezquerra G, den Heijer M, Kamsteeg M, Joosten I, Eichler EE, Lázaro C, Pujol RM, Armengol L, Abecasis G, Elder JT, Novelli G, Armour JA, Kwok PY, Bowcock A, Schalkwijk J, Estivill X. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet. 2009; 41 2: 211–215.
   PubMed Web of Science ®Google Scholar
• Gilhar A, Ullmann Y, Kerner H, Assy B, Shalaginov R, Serafimovich S, Kalish RS. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: Induction of psoriasis by cells with natural killer receptors. J Invest Dermatol. 2002; 119 2: 384–391.
   PubMed Web of Science ®Google Scholar
• Ottaviani C, Nasorri F, Bedini C, de Pità O, Girolomoni G, Cavani A. CD56brightCD16( − ) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol. 2006; 36 1: 118–128.
   PubMed Web of Science ®Google Scholar
• Cameron AL, Kirby B, Griffiths CE. Circulating natural killer cells in psoriasis. Br J Dermatol. 2003; 149 1: 160–164.
   PubMed Web of Science ®Google Scholar
• Ruckert R, Hofmann U, van der Veen C, Bulfone-Paus S, Paus R. MHC class I expression in murine skin: Developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol. 1998; 111 1: 25–30.
   PubMed Web of Science ®Google Scholar
• Paus R, Ito N, Takigawa M, Ito T. The hair follicle and immune privilege. J Investig Dermatol Symp Proc. 2003; 8 2: 188–194.
   PubMed Web of Science ®Google Scholar
• Gilhar A, Kalish RS. Alopecia areata: A tissue specific autoimmune disease of the hair follicle. Autoimmun Rev. 2006; 5 1: 64–69.
   PubMed Web of Science ®Google Scholar
• Ito T, Ito N, Saatoff M, Saatoff M, Hashizume H, Fukamizu H, Nickoloff BJ, Takigawa M, Paus R. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol. 2008; 128 5: 1196–1206.
   PubMed Web of Science ®Google Scholar
• Chiarini C, Torchia D, Bianchi B, Volpi W, Caproni M, Fabbri P. Immunopathogenesis of folliculitis decalvans: Clues in early lesions. Am J Clin Pathol. 2008; 130 4: 526–534.
   PubMed Web of Science ®Google Scholar
• Freyschmidt-Paul P, McElwee KJ, Hoffmann R, Sundberg JP, Vitacolonna M, Kissling S, Zöller M. Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br J Dermatol. 2006; 155 3: 515–521.
   PubMed Web of Science ®Google Scholar
• Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV, Meyer KC, Paus R, Jahoda CA, Amos CI, Gregersen PK, Christiano AM. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010; 466 7302: 113–117.
   PubMed Web of Science ®Google Scholar
• Kumar V, McNerney ME. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat Rev Immunol. 2005; 5 5: 363–374.
   PubMed Web of Science ®Google Scholar